According to the report, the Size of the Asia Pacific Stretch Marks Treatment Market is valued at USD xx Billion in 2021 and is projected to reach USD xx Billion by 2026, growing at a CAGR of xx% during the forecast period 2021 to 2026.
Stretch marks are a form of scarring on the skin. They may diminish over a period of time, but will not disappear completely. Stretch marks which form during pregnancy are usually on the belly, but also appear on the breasts, hips, thighs, lower back and buttocks. These are caused by tearing of the dermis. This results from rapid stretching of the skin associated with rapid growth or rapid weight changes. Hormonal changes associated with puberty, pregnancy, bodybuilding, or hormone replacement therapy also influence stretch marks.
Increasing instances of stretch marks in people of various age-group is the major driving factor. Increasing prevalence of obesity due to increased consumption of calorie-laden fast food and a sedentary lifestyle is one of the major reason of stretch marks. Increasing awareness among pregnant women highly prone to stretch marks has further propelled the market growth.
This research report on the Asia Pacific Stretch Marks Treatment Market has been segmented and sub-segmented into the following categories
By Treatment:
By End User:
By Country:
On the basis of region, the Asia Pacific has the largest market. The factors like huge population and rising disposable income drive the market. Japan and India are two important regions boosting the industry in this region.
Top Companies dominating the Asia Pacific Stretch Marks Treatment Market Profiled in the Report are Syneron Medical Ltd., E.T. Browne Drug Co., Inc., Union-Swiss (Pty) Ltd., Basq Skincare, Ellipse A/S, Laboratoires Expanscience, Clarins Group, Merz North America, Inc., Cynosure, Inc., The Boppy Company LLC, Helix BioMedix, Inc., Weleda AG, Dermaclara, Inc., Mama Mio US, Inc., and Centre Light Solutions, LLC.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Treatment
5.1.1 Introduction
5.1.2 Microdermabrasion
5.1.3 Lasers
5.1.3.1 Pulse-Dye Lasers
5.1.3.2 Fractional Lasers
5.1.3.3 Others
5.1.4 Topical Products
5.1.4.1 Creams
5.1.4.2 Lotions
5.1.4.3 Oils & Serum
5.1.4.4 Others
5.1.5 Others
5.1.6 Y-o-Y Growth Analysis, By Treatment
5.1.7 Market Attractiveness Analysis, By Treatment
5.1.8 Market Share Analysis, By Treatment
5.2 End-User
5.2.1 Introduction
5.2.2 Clinics
5.2.3 Home-use
5.2.4 Hospitals
5.2.5 Specialty Dermatology Centers
5.2.6 Others
5.2.7 Y-o-Y Growth Analysis, By End User
5.2.8 Market Attractiveness Analysis, By End User
5.2.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Treatment
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Treatment
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Treatment
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Clarins Group
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cynosure, Inc.
8.3 Merz North America, Inc.
8.4 Laboratoires Expanscience
8.5 Union-Swiss (Pty) Ltd.
8.6 Basq Skincare
8.7 The Boppy Company LLC
8.8 Helix BioMedix, Inc.
8.9 Weleda AG
8.10 Dermaclara, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
